7Baggers
 Spero Therapeutics CEO sells shares worth $121,159  MSN Tue, 30 Sep 2025 06:32:55 GMT
 TD Cowen Maintains Spero Therapeutics(SPRO.US) With Hold Rating  富途牛牛 Fri, 26 Sep 2025 15:32:43 GMT
 spero therapeutics, inc. (nasdaq:spro) short interest update  MarketBeat Fri, 19 Sep 2025 09:14:14 GMT
 spero therapeutics, inc. (nasdaq:spro) short interest update  MarketBeat Tue, 16 Sep 2025 11:17:07 GMT
 spero therapeutics, inc. (nasdaq:spro) short interest update  MarketBeat Tue, 09 Sep 2025 15:31:42 GMT
 published on: 2025-09-04 04:49:16  Newser Thu, 04 Sep 2025 09:49:16 GMT
 director sells thousands of spero therapeutics shares!  TipRanks Thu, 04 Sep 2025 06:19:18 GMT
 spero therapeutics (spro): coo keutzer sells $3.3k in stock  Investing.com India Thu, 04 Sep 2025 01:14:57 GMT
 published on: 2025-09-03 19:52:17  beatles.ru Wed, 03 Sep 2025 16:52:48 GMT
 published on: 2025-09-03 02:48:16  Newser Wed, 03 Sep 2025 07:48:16 GMT
 Spero therapeutics (SPRO): COO Keutzer sells $3.3k in stock  Investing.com Wed, 03 Sep 2025 07:00:00 GMT
 Mahadevia Ankit sells Spero Therapeutics (SPRO) stock worth $12946  Investing.com Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 23:26:02  Newser Wed, 03 Sep 2025 04:26:02 GMT
 published on: 2025-09-01 21:42:40  Newser Tue, 02 Sep 2025 02:42:40 GMT
 sentiment analysis tools applied to spero therapeutics inc.  Newser Sun, 31 Aug 2025 17:23:48 GMT
 published on: 2025-08-30 22:25:42  Newser Sun, 31 Aug 2025 03:25:42 GMT
 published on: 2025-08-30 14:47:53  Newser Sat, 30 Aug 2025 19:47:53 GMT
 published on: 2025-08-29 22:18:27  Newser Sat, 30 Aug 2025 03:18:27 GMT
 published on: 2025-08-29 18:16:31  Newser Fri, 29 Aug 2025 23:16:31 GMT
 published on: 2025-08-28 15:14:44  Newser Thu, 28 Aug 2025 20:14:44 GMT
 published on: 2025-08-28 14:16:56  Newser Thu, 28 Aug 2025 19:16:56 GMT
 published on: 2025-08-28 13:25:48  Newser Thu, 28 Aug 2025 18:25:48 GMT
 published on: 2025-08-28 05:46:49  Newser Thu, 28 Aug 2025 10:46:49 GMT
 published on: 2025-08-25 23:25:12  Newser Tue, 26 Aug 2025 04:25:12 GMT

Spero Therapeutics, Inc
(NASDAQ:SPRO) 

SPRO stock logo

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. Its product candidates include tebipenem pivoxil hydrobromide (HB...

Founded: 2013
Full Time Employees: 57
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends